Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AVITA Medical (RCEL) Total Non-Current Liabilities (2019 - 2025)

Historic Total Non-Current Liabilities for AVITA Medical (RCEL) over the last 7 years, with Q4 2025 value amounting to $71.8 million.

  • AVITA Medical's Total Non-Current Liabilities rose 36.76% to $71.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $71.8 million, marking a year-over-year increase of 36.76%. This contributed to the annual value of $71.8 million for FY2025, which is 36.76% up from last year.
  • AVITA Medical's Total Non-Current Liabilities amounted to $71.8 million in Q4 2025, which was up 36.76% from $68.5 million recorded in Q3 2025.
  • In the past 5 years, AVITA Medical's Total Non-Current Liabilities registered a high of $71.8 million during Q4 2025, and its lowest value of $8.1 million during Q1 2022.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $59.3 million (2023), whereas its average is $41.6 million.
  • Per our database at Business Quant, AVITA Medical's Total Non-Current Liabilities plummeted by 1117.81% in 2022 and then surged by 40549.1% in 2023.
  • Over the past 5 years, AVITA Medical's Total Non-Current Liabilities (Quarter) stood at $11.3 million in 2021, then grew by 3.02% to $11.6 million in 2022, then skyrocketed by 405.49% to $58.7 million in 2023, then rose by 21.8% to $71.5 million in 2024, then rose by 0.37% to $71.8 million in 2025.
  • Its Total Non-Current Liabilities stands at $71.8 million for Q4 2025, versus $68.5 million for Q3 2025 and $69.1 million for Q2 2025.